| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Simultaneous Mixed-Effects Pharmacokinetic Model for Nefopam, N-desmethylnefopam, and Nefopam N-Oxide in Human Plasma and Urine
|
Mittur, Aravind
|
|
2018
|
43 |
4 |
p. 391-404
|
artikel
|
| 2 |
Assessing Propylene Glycol Toxicity in Alcohol Withdrawal Patients Receiving Intravenous Benzodiazepines: A One-Compartment Pharmacokinetic Model
|
Jahn, Ashley
|
|
2018
|
43 |
4 |
p. 423-430
|
artikel
|
| 3 |
Drug Delivery and Transport into the Central Circulation: An Example of Zero-Order In vivo Absorption of Rotigotine from a Transdermal Patch Formulation
|
Cawello, Willi
|
|
2018
|
43 |
4 |
p. 475-481
|
artikel
|
| 4 |
Effects of Human Sulfotransferase 2A1 Genetic Polymorphisms 3 on the Sulfation of Tibolone
|
Miller, Ethan
|
|
2018
|
43 |
4 |
p. 415-421
|
artikel
|
| 5 |
Genotyping as a Key Element of Sample Size Optimization in Bioequivalence of Risperidone Tablets
|
Chen, Ying
|
|
2018
|
43 |
4 |
p. 431-439
|
artikel
|
| 6 |
Metabolism of Rhizoma coptidis in Human Urine by Ultra-High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry
|
Zhang, Qingshan
|
|
2018
|
43 |
4 |
p. 441-452
|
artikel
|
| 7 |
Model-Informed Approaches for Alternative Aripiprazole Dosing Regimens and Missed Dose Management: Towards Better Adherence to Antipsychotic Pharmacotherapy
|
Wu, Jun-Yi
|
|
2018
|
43 |
4 |
p. 471-473
|
artikel
|
| 8 |
Pharmacokinetic Properties of Saffron and its Active Components
|
Hosseini, Azar
|
|
2017
|
43 |
4 |
p. 383-390
|
artikel
|
| 9 |
Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects
|
Wang, Meng
|
|
|
43 |
4 |
p. 405-413
|
artikel
|
| 10 |
Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects
|
Wang, Meng
|
|
2018
|
43 |
4 |
p. 405-413
|
artikel
|
| 11 |
Pharmacology of Pimasertib, A Selective MEK1/2 Inhibitor
|
Srinivas, Nuggehally R.
|
|
2018
|
43 |
4 |
p. 373-382
|
artikel
|
| 12 |
Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
|
Hard, Marjie L.
|
|
2018
|
43 |
4 |
p. 461-469
|
artikel
|
| 13 |
Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics
|
Suresh, Ponnayyan Sulochana
|
|
2018
|
43 |
4 |
p. 453-460
|
artikel
|
Tijdschrift beschrijving